Long-term survival of older breast cancer patients: population-based estimates over three decades

被引:0
作者
Bindu Kanapuru
William B. Ershler
Charles Hesdorffer
Ahmedin Jemal
Jerome W. Yates
机构
[1] National Institute on Aging,Intramural Research Program
[2] Institute for Advanced Studies on Aging,Surveillance Branch
[3] American Cancer Society,undefined
来源
Breast Cancer Research and Treatment | 2012年 / 134卷
关键词
Breast cancer; Survival; Aging; SEER;
D O I
暂无
中图分类号
学科分类号
摘要
Significant progress has been made in the treatment of breast cancer. However, treatment effect on survival in older patients, particularly the “oldest old” (85+ years), with breast cancer is not clear. Data from the Surveillance, Epidemiology, and End Results databases were used to determine relative survival of older patients with breast cancer for up to 9 years following diagnosis. We compared trends in survival and stage distribution in the years 1977–1986, 1987–1996, and 1997–2006 in patients from 65 to 74, 75 to 84, and 85+ years of age. Between 1977–1986 and 1997–2006, 1 year survival increased from 94.9 to 97.9 %, 93.6 to 96.7 %, and 88.5 to 93.5 % in the 65–74, 75–84, and 85+ age groups, respectively. Survival gains increased with each year in all three age groups with the largest improvement seen at 9 years of follow-up. Although the “oldest old” had the lowest survival rates, improvement in survival was greatest in this age group with greater than 20 % increase in survival at 9 years. There was an increased diagnosis of localized breast cancer and decrease in regional disease in all age groups over the three decades. In conclusion, relative survival for older patients has increased considerably in the interval between 1977 and 2006, with the largest improvement seen in those 85 years and older. These results likely indicate that the benefit from advances in therapy and supportive care also extends to older patients with breast cancer, including the ‘oldest old’, but the impact of early diagnosis on survival requires further clarification.
引用
收藏
页码:853 / 857
页数:4
相关论文
共 42 条
[1]  
Rosso S(2010)Up-to-date estimates of breast cancer survival for the years 2000–2004 in 11 European countries: the role of screening and a comparison with data from the United States Eur J Cancer 46 3351-3357
[2]  
Gondos A(2001)Frailty in older adults: evidence for a phenotype J Gerontol A Biol Sci Med Sci 56 M146-M156
[3]  
Zanetti R(2001)Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older JAMA 285 885-892
[4]  
Fried LP(2009)Future of cancer incidence in the United States: burdens upon an aging, changing nation J Clin Oncol 27 2758-2765
[5]  
Tangen CM(2010)Fighting against age discrimination in clinical trials J Am Geriatr Soc 58 1791-1796
[6]  
Walston J(2005)Effect of screening and adjuvant therapy on mortality from breast cancer N Engl J Med 353 1784-1792
[7]  
Yancik R(2002)Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975–1999 J Natl Cancer Inst 94 1626-1634
[8]  
Wesley MN(2005)Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials Lancet 365 1687-1717
[9]  
Ries LA(2009)Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer N Engl J Med 361 766-776
[10]  
Smith BD(2006)Use and outcomes of adjuvant chemotherapy in older women with breast cancer J Clin Oncol 24 2750-2756